The number of people with diabetes worldwide is set to more than double to 1.3 billion by 2050, a new study finds, a trend accelerated by widening inequities both between and within countries. By 2050 ...
Overall, combining a low-energy diet with structured aerobic and resistance exercise achieved substantial remission in ...
The global prevalence of diabetes is rising rapidly, with the steepest increases and greatest unmet need occurring in ...
New research presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, ...
New research to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, ...
Speaking at the American Diabetes Association 84th Scientific Sessions, authors of a new Lancet Series challenge current approaches to managing gestational diabetes (a type of diabetes that can be ...
A higher weekly dose of semaglutide (7.2 mg) can significantly improve weight loss and related health outcomes in adults living with obesity, including those with type 2 diabetes (T2D), according to ...
No. 18 / 2026 Zealand Pharma to present additional data from Phase 2 ZUPREME-1 trial for petrelintide at EASD 2026 and ...
Health and Me on MSN
21% in 80 weeks: Lancet study finds Lilly’s retatrutide delivers one of the biggest weight losses ever
According to a recent Lancet study, Eli Lilly's next big weight loss drug, retatrutide, just delivered one of the biggest ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results